{"id":"https://openalex.org/W4394763718","doi":"https://doi.org/10.26355/eurrev_202403_35731","title":"Is polyethylene glycol loxenatide 100 \u03bcg the preferred glucagon-like peptide-1 receptor agonist for type 2 diabetes mellitus? A meta-analysis and trial sequential analysis.","display_name":"Is polyethylene glycol loxenatide 100 \u03bcg the preferred glucagon-like peptide-1 receptor agonist for type 2 diabetes mellitus? A meta-analysis and trial sequential analysis.","publication_year":2024,"publication_date":"2024-03-01","ids":{"openalex":"https://openalex.org/W4394763718","doi":"https://doi.org/10.26355/eurrev_202403_35731","pmid":"https://pubmed.ncbi.nlm.nih.gov/38567590"},"language":"en","primary_location":{"id":"pmid:38567590","doi":"https://doi.org/10.26355/eurrev_202403_35731","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38567590","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European review for medical and pharmacological sciences","raw_type":"Meta-Analysis"},"volume":null,"type":"review","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101442904","display_name":"Pei Liu","orcid":"https://orcid.org/0000-0002-4897-2736","observed_orcids":["https://orcid.org/0000-0002-4897-2736"]},"institutions":[{"id":"https://openalex.org/I14992734","display_name":"Hunan University of Traditional Chinese Medicine","ror":"https://ror.org/05qfq0x09","country_code":"CN","type":"education","lineage":["https://openalex.org/I14992734"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"P Liu","raw_affiliation_strings":["Hunan University of Chinese Medicine, Changsha, Hunan, China. yurong196905@163.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hunan University of Chinese Medicine, Changsha, Hunan, China. yurong196905@163.com","institution_ids":["https://openalex.org/I14992734"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108861523","display_name":"Y-F Yu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y-F Yu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101335859","display_name":"P-F Jiang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P-F Jiang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054856118","display_name":"Yang Xy","orcid":"https://orcid.org/0000-0002-6965-7751","observed_orcids":["https://orcid.org/0000-0002-6965-7751"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"X-Y Yang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111049108","display_name":"K-K Tong","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K-K Tong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061043888","display_name":"Gang Hu","orcid":"https://orcid.org/0000-0002-6172-8017","observed_orcids":["https://orcid.org/0000-0002-6172-8017","https://orcid.org/0009-0009-8605-9161","https://orcid.org/0000-0002-4901-3545"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G Hu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"S Yin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Yin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5083630398","display_name":"Rong Yu","orcid":"https://orcid.org/0009-0005-0840-2797","observed_orcids":["https://orcid.org/0009-0005-0840-2797","https://orcid.org/0000-0003-4470-3448"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R Yu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.01665675,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"28","issue":"6","first_page":"2272","last_page":"2287"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9190000295639038},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9990000128746033},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.8090000152587891},{"id":"https://openalex.org/keywords/fasting-blood-glucose","display_name":"fasting blood glucose","score":0.9490000009536743},{"id":"https://openalex.org/keywords/postprandial-blood-glucose","display_name":"postprandial blood glucose","score":0.9829999804496765},{"id":"https://openalex.org/keywords/dose-comparison","display_name":"dose comparison","score":0.6790000200271606},{"id":"https://openalex.org/keywords/gastrointestinal-side-effects","display_name":"gastrointestinal adverse effects","score":0.9660000205039978},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.9980000257492065},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6290000081062317},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.7710000276565552},{"id":"https://openalex.org/keywords/trial-sequential-analysis","display_name":"trial sequential analysis","score":0.7739999890327454}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7997130155563354},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7074333429336548},{"id":"https://openalex.org/C2778199505","wikidata":"https://www.wikidata.org/wiki/Q2992990","display_name":"Postprandial","level":3,"score":0.7072424292564392},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.6439409255981445},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6420875787734985},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.638607919216156},{"id":"https://openalex.org/C2777538456","wikidata":"https://www.wikidata.org/wiki/Q311213","display_name":"Glycated hemoglobin","level":4,"score":0.5737614035606384},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5657816529273987},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5343847274780273},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5033347010612488},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4183729290962219},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.41685691475868225},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.2812386155128479},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000097789","descriptor_name":"Glucagon-Like Peptide-1 Receptor Agonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007003","descriptor_name":"Hypoglycemia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":1,"locations":[{"id":"pmid:38567590","doi":"https://doi.org/10.26355/eurrev_202403_35731","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38567590","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European review for medical and pharmacological sciences","raw_type":"Meta-Analysis"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"},{"display_name":"Meta-Analysis","id":"https://openalex.org/study-designs/meta-analysis"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3046259606","https://openalex.org/W3088811300","https://openalex.org/W4388283217","https://openalex.org/W2301888354","https://openalex.org/W4388104043","https://openalex.org/W4378590886","https://openalex.org/W7161634929","https://openalex.org/W7167795213","https://openalex.org/W4368368251","https://openalex.org/W2039246109"],"abstract_inverted_index":{"OBJECTIVE:":[0],"This":[1],"study":[2],"aimed":[3],"to":[4,51,143,166],"systematically":[5],"evaluate":[6],"the":[7,60,63,151,154,197],"efficacy,":[8],"safety":[9,128],"and":[10,53,100,139,157,193,204],"optimal":[11],"dose":[12,152],"of":[13,30,44,160,199],"polyethylene":[14],"glycol":[15],"loxenatide":[16],"(PEX168)":[17],"for":[18,32,145,215],"treating":[19],"type":[20,75,216],"2":[21,217],"diabetes":[22,218],"mellitus":[23],"(T2DM).":[24],"MATERIALS":[25],"AND":[26],"METHODS:":[27],"Clinical":[28],"trials":[29],"PEX168":[31,67,146,161,185],"T2DM":[33],"were":[34,49,125,141,164,173],"identified":[35],"in":[36],"8":[37],"databases,":[38],"with":[39,116],"a":[40,209],"build":[41],"time":[42],"limit":[43],"January":[45],"2023.":[46],"Included":[47],"studies":[48],"subjected":[50],"meta-analysis":[52,64],"trial":[54],"sequential":[55],"analysis":[56],"(TSA).":[57],"RESULTS:":[58],"On":[59,127],"efficacy":[61],"endpoint,":[62],"showed":[65,120],"that":[66,121],"100":[68,147,167,177,186],"\u03bcg":[69,148,163,168,178,187],"significantly":[70,174,189],"reduced":[71],"0.86%":[72],"glycated":[73],"hemoglobin":[74],"A1c":[76],"(HbA1c)":[77],"(MD":[78,92,107],"-0.86,":[79],"95%":[80,94,109,180],"CI":[81,95,110,181],"-1.02":[82],"-":[83,97,112],"-0.70,":[84],"p<0.00001),":[85],"1.11":[86],"mmol/L":[87,102],"fasting":[88],"plasma":[89],"glucose":[90,105,192],"(FPG)":[91],"-1.11,":[93],"-1.49":[96],"-0.74,":[98],"p<0.00001)":[99],"1.91":[101],"2h":[103,158],"postprandial":[104],"(PPG)":[106],"-1.91,":[108],"-3.35":[111],"-0.46,":[113],"p=0.01)":[114],"compared":[115],"placebo.":[117],"The":[118],"TSA":[119],"all":[122],"these":[123],"benefits":[124],"conclusive.":[126],"endpoints,":[129],"total":[130,200],"adverse":[131],"events":[132],"(AEs),":[133],"gastrointestinal":[134],"(GI)":[135],"AEs,":[136,138,201,203],"serious":[137],"hypoglycemia":[140],"comparable":[142,165],"placebo":[144],"(p>0.05).":[149],"In":[150],"comparison,":[153],"HbA1c,":[155],"FPG,":[156],"PPG":[159],"200":[162],"(p>0.05),":[169],"while":[170],"GI":[171,202],"AEs":[172],"higher":[175],"than":[176],"(RR=2.84,":[179],"1.64-4.93,":[182],"p=0.0002).":[183],"CONCLUSIONS:":[184],"can":[188],"lower":[190],"blood":[191],"does":[194],"not":[195],"increase":[196],"risk":[198],"hypoglycemia,":[205],"which":[206],"may":[207],"be":[208],"preferred":[210],"glucagon-like":[211],"peptide-1":[212],"receptor":[213],"agonist":[214],"mellitus.":[219]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-04-13T00:00:00"}